Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 4,066 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Hypertension, Hyperlipidemia, Coronary Artery Disease, Diabetes Mellitus
Interventions: Education; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 282 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Lung Carcinoma
Interventions: Educational Intervention, Exercise Intervention, Medical Device Usage and Evaluation, Physical Performance Testing, Quality-of-Life Assessment, Questionnaire Administration; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 382 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 16
States / cities: Davis, California • Duarte, California • Irvine, California + 13 more

Conditions: Cigarette Smoking, E-Cigarette Use, Smoking Cessation
Interventions: Varenicline, Counseling, Guided Self-Change Booklets; Drug · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Nicotine, E-liquid Flavors
Interventions: Nicotine 0 mg/mL, Nicotine 6 mg/mL, Nicotine 12 mg/mL, Nicotine 24 mg/mL, 'Menthol' flavor, 'Menthol/Mint' flavor, 'Green Apple' flavor, 'Watermelon' flavor, 'Unflavored'; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Adolescent Obesity, Diabetes Mellitus
Interventions: Black Girls Move; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 12 Years to 18 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Melanoma, Survivors, Psychological Factors
Interventions: Focus group, Survey; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Moderate and Severe Active Rheumatoid Arthritis, Active Psoriatic Arthritis, Active Ankylosing Spondylitis, Moderately to Severely Active Crohn's Disease
Interventions: e-Device; Drug
Lead sponsor: UCB Biopharma S.P.R.L.; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 22
States / cities: Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 15 more

Conditions: Cardiac Dysfunction, Neurocognitive Disease, Chronic Pain, Sleep Apnea
Interventions: Echocardiography, Neuropsychological Testing, Quantitative Sensory Testing, Nocturnal Polysomnography; Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 24 Years to 55 Years · Male only
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cerebrovascular Accident
Interventions: TR intervention, In-home messaging device., Usual care; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 45 Years to 90 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 3
States / cities: Decatur, Georgia • Indianapolis, Indiana • Durham, North Carolina

Conditions: Any Cancer Diagnosis
Interventions: Play Intervention, Questionnaires; Behavioral · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 4 Years to 10 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Breast Cancer
Interventions: Harvard Health Professionals survey, Blood draw, CPET Procedures, stool sample, Research Tissue sampling; Behavioral · Other · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years to 80 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Diabetes BOOST, Usual Care; Behavioral
Lead sponsor: Daniel Amante; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Burnout, Healthcare Workers, Anxiety, Wellness Program, Depression Not Otherwise Specified
Interventions: Wellness Intervention; Behavioral
Lead sponsor: University of Nevada, Reno; Other
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Urethritis, Healthy Men Age 18-50 With no Urethral Symptoms
Interventions: Colli-Pee, standard of care 60 mL urine cup, Urinalysis, Sysmex UP-5000; Device · Diagnostic Test
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Migraine
Interventions: RELAXaHEAD Smartphone App Version 1, RELAXaHEAD Smartphone App Version 2; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 16 Years to 80 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: Peer Led, Seminar; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 404 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Physical Inactivity, Sedentary Behavior, Sleep, Cognitive Function
Interventions: Education, Health coaching, Activity Monitor; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 80 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)
Interventions: Apraglutide, Placebo; Drug
Lead sponsor: VectivBio AG; Industry
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 17
States / cities: Los Angeles, California • Denver, Colorado • Washington D.C., District of Columbia + 14 more

Conditions: Diabetes
Interventions: G3 Investigational Blood Glucose Monitoring System; Device
Lead sponsor: Ascensia Diabetes Care; Industry
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 2
States / cities: Fairfield, New Jersey • Santa Fe, New Mexico

Conditions: Asthma, Parkinson's Disease
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 24 Years and older
Enrollment: 89,656 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 3
States / cities: Iowa City, Illinois • Research Triangle Park, North Carolina • Columbus, Ohio

Conditions: Medication Adherence, Kidney Transplantation
Interventions: Adherence Intervention, Healthy living education intervention; Behavioral · Other
Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre; Other
Eligibility: 12 Years to 24 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: St Louis, Missouri • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania + 1 more

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: HTN Educational Video, Visual Echocardiogram Image Clips, Mobile Health and Remote BP monitoring, Post-Acute Care HTN Transition consultation (PACHT-c); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Relapsing Forms of Multiple Sclerosis
Interventions: Ocrelizumab, Ofatumumab; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Lutherville, Maryland

Conditions: Type 2 Diabetes
Interventions: Enhanced Telemedicine for Type 2 Diabetes, Usual Telemedicine Endocrinology Care for T2D; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Veterans Service Organizations and My HealtheVet (MHV)

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use

Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes

Black Girls Move Physical Activity and Improving Dietary Intake Among Black Adolescent Daughters

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Football Players Health Study In Person Assessments Study

Home-based Telehealth Stroke Care: A Randomized Trial for Veterans

A Cognitive- Behavioral Play Intervention for Siblings of Children Diagnosed With Cancer

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Development and Feasibility Testing of DM-BOOST Intervention.

The Counselor Led Resident Wellness Study

Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men

RELAXaHEAD for Headache Patients (Phase III)

Working With Veterans Organizations to Improve Blood Pressure

Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study

A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

Study of an Investigational Glucose Meter System

Agricultural Health Study Follow-up

Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

Targeting of UnControlled Hypertension in Emergency Department

Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis

Enhancing Telemedicine for T2D